OncoCyte Ownership | Who Owns OncoCyte?


OverviewForecastRevenueFinancialsChartTranscripts

OncoCyte Ownership Summary


OncoCyte is owned by 0.43% institutional investors, 15.96% insiders, and 83.61% retail investors. Defender capital, llc. is the largest institutional shareholder, holding 0.67% of OCX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.92% of its assets in OncoCyte shares.

OCX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOncoCyte0.43%15.96%83.61%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Defender capital, llc.55.22K0.67%$162.90K
Awm investment company---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Defender capital, llc.55.22K0.06%$162.90K
Awm investment company---

Top Buyers

HolderShares% AssetsChange
Defender capital, llc.55.22K0.06%-665.00
Awm investment company---1.10M

Top Sellers

HolderShares% AssetsChange
Awm investment company---1.10M
Defender capital, llc.55.22K0.06%-665.00

Sold Out

HolderChange
Awm investment company-1.10M

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241-50.00%59,353-94.85%-0.22%1---100.00%
Jun 30, 20242-1,152,39542.24%1312.44%1-1-
Mar 31, 20242-810,171-1.91%1010.58%--100.00%1-
Dec 31, 20232-825,936-0.94%109.42%1-1-50.00%
Sep 30, 20232-95.74%833,802-99.09%100.17%--100.00%2-71.43%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv154.88K0.92%-
Vanguard Institutional Extnd Mkt Idx Tr85.00K0.50%-
Fidelity Extended Market Index68.85K0.41%-278.00
iShares Micro-Cap ETF18.03K0.11%-
NT Ext Equity Mkt Idx Fd - L11.96K0.09%-
Northern Trust Extended Eq Market Idx11.96K0.09%-
Fidelity Total Market Index12.25K0.07%5.69K
BlackRock Extended Equity Market K9.28K0.07%-4.00
Fidelity Series Total Market Index11.53K0.07%4.25K
NT Ext Equity Mkt Idx Fd - NL4.90K0.04%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 05, 2024James Andrea S. Chief Financial OfficerBuy$45.80K
Oct 02, 2024James Andrea S. Chief Financial OfficerBuy$100.00K
Oct 02, 2024BROADWOOD PARTNERS, L.P.-Buy-
Oct 02, 2024BROADWOOD PARTNERS, L.P.-Buy$3.88M
Apr 11, 2024BROADWOOD PARTNERS, L.P.-Buy-

Insider Transactions Trends


DateBuySell
2024 Q43-
2024 Q3--
2024 Q24-
2023 Q4--
2023 Q3--

OCX Ownership FAQ


Who Owns OncoCyte?

OncoCyte shareholders are primarily institutional investors at 0.43%, followed by 15.96% insiders and 83.61% retail investors. The average institutional ownership in OncoCyte's industry, Biotech Stocks , is 47.04%, which OncoCyte falls below.

Does Blackrock own OncoCyte?

BlackRock is not among the top 10 institutional shareholders of OncoCyte.

Who is OncoCyte’s biggest shareholder by percentage of total assets invested?

Defender capital, llc is OncoCyte’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 55.22K OncoCyte shares, valued at 162.9K$.

Who is the top mutual fund holder of OncoCyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of OncoCyte shares, with 0.92% of its total shares outstanding invested in 154.88K OncoCyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools